These consistent findings across all three studies highlight a notable trend of robust medication adherence among the study cohorts.
← all excerpts
Real-world analysis of safety, tolerability, and adherence to nirmatrelvir-ritonavir (paxlovid) in primary care COVID-19 outpatients.
1
—
—